Lisata appoints James Nisco as SVP, Finance & Treasury and CAO

LISATA THERAPEUTICS, INC.

James Nisco appointed Senior Vice President, Finance and Treasury and Chief Accounting Officer effective April 15, 2024.
Nisco will serve as principal financial officer and principal accounting officer.
Annual base salary set at $350,000 with a short-term incentive bonus target of 35% of base.
Nisco previously served as Vice President of Finance & Treasury since August 2020, an internal promotion.
No family relationships with directors/executives; no reportable transactions under Item 404.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Nisco

Senior Vice President, Finance and Treasury and Chief Accounting Officer

LSTA · LISATA THERAPEUTICS, INC.

Effective: 2024-04-15
Filed: April 17, 2024, 7:59 PM ET

On April 15, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) appointed James Nisco as the Company’s Senior Vice President, Finance and Treasury and Chief Accounting Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James Nisco was appointed as Senior Vice President, Finance and Treasury and Chief Accounting Officer at LISATA THERAPEUTICS, INC..

Action: appointed
Role: Senior Vice President, Finance and Treasury and Chief Accounting Officer

Exact text from the filing

On April 15, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) appointed James Nisco as the Company’s Senior Vice President, Finance and Treasury and Chief Accounting Officer, effective immediately.

View on SEC.gov

LISATA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0000320017-24-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.